摘要
目的:探讨血糖升高的急性脑梗死(ACI)患者测定糖化血红蛋白(GHb)的临床意义。方法:测定136例空腹血糖升高的脑梗死患者的糖化血红蛋白,分为GHb正常组(GHbA1c<6.0%),GHb升高组(GHbA1c≥6.0%),将两组神经功能缺损、临床疗效进行比较。结果:急性脑梗死患者糖化血红蛋白升高组比糖化血红蛋白正常组神经功能缺损程度重,临床疗效欠佳。结论:糖化血红蛋白可作为患者评估愈后和指导治疗的有效指标之一。
Objective：To explore the clinical significance of glycosylated hemogiobin （GHb） in high fasting blood-glucose acute cerebral infarction （ACI）. Methods：136 cases of high fasting biood-glucose ACI were divided into the normal GHb group and the high GHb group,the neurological deficit and clinical efficacy between high GHb group and the normal one were compared. Results：The infarct lesion size of high GHb group was larger and the improving rate was lower than that of the normal group. Conclusion：GHb can be used as one of the indices for state and prognoses prediction in high fasting blood-glucose ACI patients. It is very significant in guiding timely comprehensive treatment.
出处
《中国当代医药》
2010年第23期30-31,共2页
China Modern Medicine
关键词
糖化血红蛋白
血糖
急性脑梗死
Glycosylated hemogiobin
Blood glucose
Acute cerebral infarction
